atai Life Sciences (ATAI) Reports In-Line Q3 EPS

atai Life Sciences (NASDAQ: ATAI) reported Q3 EPS of ($0.16), in-line with the analyst estimate of ($0.16).

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Super League Enterprise (SLE) files for 1.07M share offering by selling stockholders
• MagnaChip (MX) files $50M mixed shelf